Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

May 22, 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

News Conference News EuroPCR 2024

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

Yael L. Maxwell

May 16, 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

AnchorMan LAAO Device Matches Up Well With the Watchman

News Conference News EuroPCR 2023

AnchorMan LAAO Device Matches Up Well With the Watchman

May 19, 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

May 18, 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

June 07, 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

May 23, 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

May 25, 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

May 24, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.